EX-16.2 18 tm2232413d1_ex16-2.htm EXHIBIT 16.2


Exhibit 16.2

 

December 12, 2022

 

Securities and Exchange Commission

 

Washington, D.C. 20549

 

Commissioners:

 

We have read Prosomnus, Inc.’s statements included under Item 4.01 of its Form 8-K filed on December 12, 2022, and we agree with such statements concerning our Firm.

 

/s/ SingerLewak LLP